Suggestions
Emma Stanton
SVP Clinical at Oxford Nanopore Technologies 🔹 Non-Executive Director
Emma Stanton is the Senior Vice President of Clinical Affairs and Head of Oxford Nanopore Diagnostics at Oxford Nanopore Technologies. She has held this position since 2020, contributing significantly to the company's focus on innovative diagnostic solutions.
Education and Background::
- Dr. Stanton has a background in clinical research and diagnostics, with educational credentials from Harvard Business School, which enhances her expertise in the field.
Professional Experience::
- Prior to her role at Oxford Nanopore Technologies, Emma Stanton has accumulated extensive experience in various leadership positions, demonstrating her capabilities in driving clinical strategies and operational excellence within the biotechnology sector.
Current Role::
- As Senior Vice President, she oversees the clinical development and implementation of diagnostic products that utilize Oxford Nanopore's unique sequencing technology, aiming to improve healthcare outcomes through accessible genomic information.
Stanton's leadership is pivotal in advancing the company's mission to democratize access to DNA sequencing and enhance the capabilities of diagnostic testing globally.
Highlights
I cannot recommend Commonwealth Fund Harkness Fellowships enough. For any mid-career health care folk pondering what next, take a look as applications open now --> https://lnkd.in/dmNzwnrd Some good adverts here --> Jacob West James Mountford Claire Lemer Thomas Lee, MD Jennifer Dixon Anna Dixon Martin Marshall Alice Murray
We have just concluded a deeply inspiring day at the Oxford Nanopore Technologies London Calling 2024 conference, where we had the privilege of engaging with some of the brightest leaders globally in the field of genomic medicine.
Today's sessions underscored the transformative impact that our technology is making across the healthcare spectrum as well as the potential to transform the biopharma industry.
#NanoporeConf Nabihah Sachedina Gordon Sanghera Professor Ian Abbs jonathan edgeworth Emma White Kathleen C. Barnes Genomics England Guy's and St Thomas' NHS Foundation Trust Alina Lemnrau Ham Carolyn Tregidgo bioMérieux Chris Swagell Justin O'Grady Rosemary Sinclair Dokos Benjamin Kipp, PhD, FACMG Mayo Clinic
